Samsung Bioepis takes aim at patents for eye disease biosimilar

Intellectual Property 2023-11-09 11:23 pm By Cat Fredenburgh

South Korean biosimilars company Samsung Bioepis has sued to invalidate two patents held by a German competitor for a pre-filled syringe to treat age-related eye diseases, as generic drug makers race for a piece of the lucrative eye drug market.